Patents : |  |
| US Patent No. | Title |
| 7449554 | Antibodies against the PRO4977 polypeptides
|
| 7488586 | PRO4409 polypeptides
|
| 7488588 | Compounds related to or derived from GFR .alpha.4 and their use
|
| 7488796 | PRO1269 polypeptides
|
| 7491797 | PRO6308 polypeptide
|
| 7495082 | Antibodies to PRO4349 polypeptides
|
| 7495083 | PRO940 antibodies
|
| 7504480 | PRO10275 polypeptides
|
| 7507404 | Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
| 7507766 | Treatment of cancers
|
| 7510700 | Pathological tissue detection and treatment employing targeted benzoindole optical agents
|
| 7485308 | 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor
|
| 7482147 | Ubiquitin protease
|
| 7479545 | PRO6001 antibodies
|
| 7452551 | Targeted compositions for diagnostic and therapeutic use
|
| 7452975 | Anti-PRO7168 antibodies
|
| 7459155 | Treating abdominal pain due to pancreatitis with seaprose
|
| 7459448 | Lactam compounds useful as protein kinase inhibitors
|
| 7465785 | Polypeptide encoded by a nucleic acid over-expressed in melanoma
|
| 7465786 | PRO1801 polypeptides
|
| 7468363 | Methods for treatment of cancers using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
|
| 7468424 | Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
| 7470667 | Methods of treating cancer using a modified endostatin protein
|
| 7476721 | Modified cytokines for use in cancer therapy
|
| 7517440 | Electrokinetic delivery systems, devices and methods
|
| 7517890 | GTPase inhibitors and methods of use
|
| 7569597 | Isoindoline compounds and methods of their use
|
| 7569672 | Antibodies that bind to EphA2 and methods of use thereof
|
| 7572284 | Method for automated localization of lesions in the gastrointestinal tract for treatment using laser light from an endorobot
|
| 7572784 | Compounds and methods for inhibiting mitotic progression
|
| 7572895 | Transferrin receptor antibodies
|
| 7572896 | Antibodies to oncostatin M receptor
|
| 7582293 | Anti-PRO6308 antibodies
|
| 7589172 | PRO256 polypeptides
|
| 7598341 | Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs
|
| 7598375 | Method of acylating maytansinol with chiral amino acids
|
| 7566774 | PRO4977 polypeptides
|
| 7563867 | PRO4356 polypeptides
|
| 7560111 | HER2 antibody composition
|
| 7521539 | Anti-PRO4989 antibodies
|
| 7527791 | Humanized anti-TGF-beta antibodies
|
| 7527969 | RAAG10 cell surface target and a family of antibodies recognizing that target
|
| 7528235 | Multi-functional antibodies
|
| 7534856 | PRO19624 antibodies
|
| 7538086 | PRO1303 polypeptides
|
| 7541018 | Treatment process using somatostatin analogues
|
| 7550256 | Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
|
| 7553659 | CHD5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof
|
| 7557190 | Optimized proteins that target Ep-CAM
|
| 7611879 | 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor
|
